Related Experiment Video
Updated: Sep 28, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
How did the adoption of wP-pentavalent affect the global paediatric vaccine coverage rate? A multicountry panel data
M Mahmud Khan1, Juan Camilo Vargas-Zambrano2, Laurent Coudeville3
1Department of Health Policy and Management, University of Georgia, Athens, Georgia, USA.
Insights
Combination vaccines, like the pentavalent vaccine, significantly boosted global immunization coverage for diphtheria, tetanus, pertussis (DTP3), hepatitis B (HepB3), and Haemophilus influenzae type B (Hib3). These vaccines are crucial for improving childhood vaccine uptake worldwide.
Area of Science:
- Immunology
- Global Health
- Vaccinology
Background:
- Combination vaccines have been shown to improve immunization coverage at national and subnational levels.
- The global impact of combination vaccines on immunization coverage has not been extensively studied.
Purpose of the Study:
- To examine the global effects of introducing the whole-cell pertussis pentavalent (wP-pentavalent) vaccine.
- To estimate the incremental coverage effects of combination vaccines on diphtheria, tetanus, pertussis (DTP3), hepatitis B (HepB3), and Haemophilus influenzae type B (Hib3) vaccine doses.
Main Methods:
- Utilized multicountry panel data from WHO/UNICEF, covering the years 1980-2018.
- Employed linear mixed models to estimate the impact of wP-pentavalent introduction.
- Incorporated proxy variables to control for time trends and other changes in immunization programs.
Main Results:
- Introduction of wP-pentavalent vaccine globally increased DTP3 coverage by approximately 3% compared to the pre-combination vaccine era.
- Combination vaccines improved HepB3 and Hib3 coverage by 10.1% and 9.9%, respectively, in countries that had introduced these antigens earlier.
- The introduction of pentavalent vaccine facilitated the inclusion of Hib and HepB in the vaccine schedules of a large number of countries.
Conclusions:
- The development of combination vaccines with additional antigens is likely to sustain and improve coverage for both existing and new childhood vaccines.
- Combination vaccines play a vital role in enhancing global immunization efforts and expanding vaccine access.
Objectives:
Several studies have highlighted the effects of combination vaccines on immunisation coverage at the national or subnational level. This study examined the effects globally. Worldwide introduction of whole-cell pertussis pentavalent (wP-pentavalent) allowed estimation of incremental coverage effects of combination vaccines on the third doses of diphtheria, tetanus, pertussis (DTP3); hepatitis B (HepB3) and Haemophilus influenzae type B (Hib3).
Design:
Multicountry panel data analysis.
Data Sources:
Country-level vaccine coverage data of WHO/UNICEF for the years 1980-2018.
Methods:
Linear mixed models were used to estimate the effects of wP-pentavalent introduction by incorporating proxy variables to control for time trend and other time-dependent changes in the immunisation programmes.
Results:
Introduction of combination vaccines may have improved the coverage of DTP3 by 3percentage points(95% CI 2.5% to 3.6%) globally compared with the coverage in the pre-combination vaccine era. The comparison of coverage rates of HepB3 and Hib3 in before and after wP-pentavalent periods indicates that the introduction of combination vaccines improved the coverage by 10.1 percentage points (95% CI 8.4% to 11.7%) for HepB3 and 9.9 (95% CI 7.1% to 12.7%) for Hib3 in countries that introduced those antigens prior to adoption of wP-pentavalent. Even though the incremental coverage increase of DTP3 appears quite modest, it is still a significant result, especially because DTP vaccine has been in the national immunisation programmes of all countries for about 24 years prior to the introduction of wP-pentavalent. Additionally, the introduction of pentavalent also allowed inclusion of Hib and HepB in the vaccine schedule for a large number of countries (85 and 37, respectively, of the 102 countries included in our analysis).
Conclusion:
The findings suggest that development of combination vaccines with additional antigens is likely to help sustain and improve coverage of existing as well as new childhood vaccines.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Related Concept Videos
Vaccinations
Analysis of Population Pharmacokinetic Data
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Bias in Epidemiological Studies
Teratogenicity
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...